The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Hosted on MSN56m
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback